Patent details
EP2249861 Title: PROGRANULIN FOR USE IN TREATING PARKINSON'S DISEASE OR ALZHEIMER'S DISEASE
Basic Information
- Publication number:
- EP2249861
- PCT Application Number:
- PCT/CA/2009/000074
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097016471
- PCT Publication Number:
- WO/2009/089635
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROGRANULIN FOR USE IN TREATING PARKINSON'S DISEASE OR ALZHEIMER'S DISEASE
- French Title of Invention:
- PROGRANULIN POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON OU D'ALZHEIMER
- German Title of Invention:
- PROGRANULIN ZUR BEHANDLUNG DER PARKINSON-KRANKHEIT ODER ALZHEIMER-KRANKHEIT
- SPC Number:
Dates
- Filing date:
- 16/01/2009
- Grant date:
- 21/05/2024
- EP Publication Date:
- 06/07/2016
- PCT Publication Date:
- 23/07/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/11/2010
- EP B1 Publication Date:
- 06/07/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/01/2017
- Expiration date:
- 16/01/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/01/2009
- Name:
- Neurodyn Life Sciences Inc.
- Address:
- Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3, Canada (CA)
Inventor
- Name:
- KAY Denis G.
- Address:
- Canada (CA)
Priority
1
- Priority Number:
- 11253
- Priority Date:
- 13/11/2001
- Priority Country:
- United States (US)
2
- Priority Number:
- 11284
- Priority Date:
- 16/01/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/17;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|